Your browser doesn't support javascript.
loading
A phase I/Ib study of regorafenib and nivolumab in mismatch repair proficient advanced refractory colorectal cancer.
Kim, Richard D; Kovari, Bence P; Martinez, Maria; Xie, Hao; Sahin, Ibrahim H; Mehta, Rutika; Strosberg, Jonathan; Imanirad, Iman; Ghayouri, Masoumeh; Kim, Young-Chul; Kim, Dae Won.
Afiliación
  • Kim RD; Department of Gastrointestinal Oncology, Moffitt Cancer Center, Tampa, FL, USA. Electronic address: richard.kim@moffitt.org.
  • Kovari BP; Department of Pathology, Moffitt Cancer Center, Tampa, FL, USA.
  • Martinez M; Department of Gastrointestinal Oncology, Moffitt Cancer Center, Tampa, FL, USA.
  • Xie H; Department of Gastrointestinal Oncology, Moffitt Cancer Center, Tampa, FL, USA.
  • Sahin IH; Department of Gastrointestinal Oncology, Moffitt Cancer Center, Tampa, FL, USA.
  • Mehta R; Department of Gastrointestinal Oncology, Moffitt Cancer Center, Tampa, FL, USA.
  • Strosberg J; Department of Gastrointestinal Oncology, Moffitt Cancer Center, Tampa, FL, USA.
  • Imanirad I; Department of Gastrointestinal Oncology, Moffitt Cancer Center, Tampa, FL, USA.
  • Ghayouri M; Department of Pathology, Moffitt Cancer Center, Tampa, FL, USA.
  • Kim YC; Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, FL, USA.
  • Kim DW; Department of Gastrointestinal Oncology, Moffitt Cancer Center, Tampa, FL, USA.
Eur J Cancer ; 169: 93-102, 2022 07.
Article en En | MEDLINE | ID: mdl-35526308

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Neoplasias del Colon / Exantema Límite: Humans Idioma: En Revista: Eur J Cancer Año: 2022 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Neoplasias del Colon / Exantema Límite: Humans Idioma: En Revista: Eur J Cancer Año: 2022 Tipo del documento: Article